Tirzepatide

The US Food and Drug Administration has approved this innovative drug to treat type 2 diabetes mellitus. It is also effective in helping people lose weight, which is why it is used off-label to treat obesity. It functions as a dual agonist for the insulinotropic polypeptide receptors that are dependent on glucose and the glucagon-like peptide-1 receptor.